3,547
Views
10
CrossRef citations to date
0
Altmetric
Perspective

Streamlining drug discovery assays for cardiovascular disease using zebrafish

, &
Pages 27-37 | Received 22 Mar 2019, Accepted 19 Sep 2019, Published online: 01 Oct 2019

Figures & data

Table 1. Pharmacological impact of common human cardiovascular drugs on zebrafish.

Table 2. Selected zebrafish mutants as models for human CVD.

Figure 1. Essential electrocardiographic parameters including p-wave, QRS complex, and T-wave, between (a) humans and (b) zebrafish are similar. Also, de- and repolarizing ion currents during action potential of human and zebrafish cardiomyocyte share common characteristics. (c) QT interval measurement by electrocardiogram (ECG) in embryonic wild-type zebrafish with normal QT interval in comparison to (D) prolonged QT interval in a zebrafish mutant with prolonged myocardial repolarization. (adapted from [Citation14] and [Citation51] with permission of Bentham Science Publishers and Elsevier, respectively).

Figure 1. Essential electrocardiographic parameters including p-wave, QRS complex, and T-wave, between (a) humans and (b) zebrafish are similar. Also, de- and repolarizing ion currents during action potential of human and zebrafish cardiomyocyte share common characteristics. (c) QT interval measurement by electrocardiogram (ECG) in embryonic wild-type zebrafish with normal QT interval in comparison to (D) prolonged QT interval in a zebrafish mutant with prolonged myocardial repolarization. (adapted from [Citation14] and [Citation51] with permission of Bentham Science Publishers and Elsevier, respectively).